|
ZNF138 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.365200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.048600E-01 |
| Normal-vs-Stage2 |
6.645000E-01 |
| Normal-vs-Stage3 |
5.374400E-02 |
| Normal-vs-Stage4 |
7.057200E-01 |
| Stage1-vs-Stage2 |
2.905400E-01 |
| Stage1-vs-Stage3 |
2.281200E-01 |
| Stage1-vs-Stage4 |
4.647600E-01 |
| Stage2-vs-Stage3 |
1.149400E-01 |
| Stage2-vs-Stage4 |
9.504400E-01 |
| Stage3-vs-Stage4 |
1.132440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.375600E-01 |
| Normal-vs-AfricanAmerican |
8.654000E-01 |
| Normal-vs-Asian |
6.667000E-01 |
| Caucasian-vs-AfricanAmerican |
4.284000E-01 |
| Caucasian-vs-Asian |
5.936800E-01 |
| AfricanAmerican-vs-Asian |
8.248400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.555200E-01 |
| Normal-vs-Female |
9.543600E-01 |
| Male-vs-Female |
5.887400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.344000E-01 |
| Normal-vs-Extreme_Weight |
3.771200E-01 |
| Normal-vs-Obese |
9.106600E-01 |
| Normal-vs-Extreme_Obese |
8.447400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.638800E-01 |
| Normal_Weight-vs-Obese |
4.648400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.305600E-01 |
| Extreme_Weight-vs-Obese |
4.394400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.474800E-01 |
| Obese-vs-Extreme_Obese |
8.518600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.857600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.959600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.832000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.289500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.426400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.262400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.978200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.772550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.930500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.087600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.639200E-01 |
| Normal-VS-Type2 PRCC |
2.552300E-02 |
| Normal-VS-KIRP CIMP |
8.123200E-01 |
| Normal-VS-Unclassified PRCC |
5.000400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.036300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.975000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.648200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.237550E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.878620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.679200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.501100E-03 |
| Normal-vs-N1 |
7.142600E-01 |
| Normal-vs-N2 |
1.207440E-01 |
| N0-vs-N1 |
1.075930E-02 |
| N0-vs-N2 |
6.865200E-01 |
| N1-vs-N2 |
1.771760E-01 |
|
|
